Improving adverse drug reaction reporting in hospitals: results of the French Pharmacovigilance in Midi-Pyrénées region (PharmacoMIP) network 2-year pilot study.
about
Impact of information letters on the reporting rate of adverse drug reactions and the quality of the reports: a randomized controlled study.A systematic review of the prevalence and risk factors for adverse drug reactions in the elderly in the acute care settingTexting-Based Reporting of Adverse Drug Reactions to Ensure Patient Safety: A Feasibility StudyStrategies to improve adverse drug reaction reporting: a critical and systematic review.Impact of educational interventions on adverse drug events reporting.Completeness of Spontaneous Adverse Drug Reaction Reports Sent by General Practitioners to a Regional Pharmacovigilance Centre: A Descriptive Study.Effect of an educational intervention to improve adverse drug reaction reporting in physicians: a cluster randomized controlled trial.Complications of BCG vaccine SSI® recent story and risk management plan: the French experience.Defining 'surveillance' in drug safety.Knowledge, attitudes and perspective on adverse drug reaction reporting in a public sector hospital in South Africa: baseline analysis.Adverse Drug Reaction Reports Received Through the Mobile App, VigiBIP®: A Comparison with Classical Methods of Reporting.Adverse drug reactions: analysis of spontaneous reporting system in Europe in 2007-2009.Workshop- and telephone-based interventions to improve adverse drug reaction reporting: a cluster-randomized trial in Portugal.
P2860
Q31030474-B958470F-C7E7-4652-8CB7-735E0C041FD7Q34637462-933D3DE5-7209-4984-B9A0-1C57FE5A3BBAQ36907167-CB705957-DF68-4C0A-A543-84073755A65CQ38103821-092F7F27-65AF-448B-B140-4C44A9FCF286Q38167448-55D94300-DEFA-462D-89D3-D340A5A47AE2Q39336264-FBF2EB73-6BC9-4C12-92DE-9D7C84F2E6B1Q41653914-C0D2054C-DC55-44C5-B3A3-F9DD4A4ED39DQ44608649-C3355DDC-8C60-4C2E-A062-E8954C370071Q46407927-C1C1B87F-C5F5-4CEF-9B27-D7FA9A296347Q46922930-2A76D954-C26D-44D3-8FBF-3F2875065915Q47186746-285A7388-83F0-4FB7-901A-9B01F1C9EBB2Q51177476-2C813A95-1604-46B3-BA13-380B72916104Q52802544-8BC8C838-2DD4-4D7F-88E9-F3BBD526389D
P2860
Improving adverse drug reaction reporting in hospitals: results of the French Pharmacovigilance in Midi-Pyrénées region (PharmacoMIP) network 2-year pilot study.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
Improving adverse drug reactio ...... P) network 2-year pilot study.
@en
Improving adverse drug reactio ...... ilance in Midi-Pyrénées region
@nl
type
label
Improving adverse drug reactio ...... P) network 2-year pilot study.
@en
Improving adverse drug reactio ...... ilance in Midi-Pyrénées region
@nl
prefLabel
Improving adverse drug reactio ...... P) network 2-year pilot study.
@en
Improving adverse drug reactio ...... ilance in Midi-Pyrénées region
@nl
P2093
P1433
P1476
Improving adverse drug reactio ...... P) network 2-year pilot study.
@en
P2093
Agnès Sommet
Dominique Baudrin
Haleh Bagheri
Jean Louis Montastruc
Julien Jacquot
Kattalin Badie
Mireille Gony
Pierre Gauthier
P2860
P304
P356
10.2165/11319170-000000000-00000
P577
2010-05-01T00:00:00Z
P5875
P6179
1017992013